Literature DB >> 14201141

THE REVERSAL OF CYTOSINE ARABINOSIDE ACTIVITY IN VIVO BY DEOXYCYTIDINE.

J S EVANS, G D MENGEL.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR; CYTOSINE; EXPERIMENTAL LAB STUDY; LEUKEMIA, EXPERIMENTAL; NEOPLASMS, EXPERIMENTAL; NUCLEOSIDES; PHARMACOLOGY; SARCOMA 180, CROCKER

Mesh：

Substances：

Year:  1964        PMID： 14201141     DOI： 10.1016/0006-2952(64)90095-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  5 in total

1.  4'-Ethynyl nucleoside analogs: potent inhibitors of multidrug-resistant human immunodeficiency virus variants in vitro.

Authors:  E I Kodama; S Kohgo; K Kitano; H Machida; H Gatanaga; S Shigeta; M Matsuoka; H Ohrui; H Mitsuya
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  Intra-arterial cancer chemotherapy with combined anticancer agents.

Authors:  S Fujimoto; T Miyoshi; Y Nomura; T Akao; B Ito
Journal:  Jpn J Surg       Date:  1973-03

3.  2'-Deoxycytidine hydrochloride protection of mice against the lethal toxicity of cytosine arabinoside. Absence of protection of bone marrow lymphocytes.

Authors:  V M Buchman; N I Belyanchikova; D M Mkheidze; T A Litovchenko; M R Lichinitser; M F Barkhotkina; G J Svet-Moldavsky
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

4.  Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitro.

Authors:  S Hayashi; D W Norbeck; W Rosenbrook; R L Fine; M Matsukura; J J Plattner; S Broder; H Mitsuya
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

Review 5.  Metabolic reprogramming and epigenetic modifications on the path to cancer.

Authors:  Linchong Sun; Huafeng Zhang; Ping Gao
Journal:  Protein Cell       Date:  2021-05-29       Impact factor: 15.328
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.